“Glucose-Responsive Nanoparticles for Targeted Insulin Delivery in the Treatment of Diabetes” (2025) Journal of Carcinogenesis, 24(4s), pp. 914–927. doi:10.64149/J.Carcinog.24.4s.914-927.